Literature DB >> 16082321

2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?

Waichi Wong1, Jean-Pierre Venetz, Nina Tolkoff-Rubin, Manuel Pascual.   

Abstract

The calcineurin inhibitors (CNIs) cyclosporine and tacrolimus have been the cornerstones of immunosuppressive strategies in clinical transplantation. Currently, regimens that are most widely used for induction and maintenance therapy include CNIs. However, many clinical trials aiming at reducing or eliminating CNIs have been performed in recent years. Here, we review and discuss current and future immunosuppressive strategies with a special emphasis on the role of CNIs, in the light of recent studies in the field of kidney transplantation. In the current era, CNIs still play an important role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082321     DOI: 10.1097/01.tp.0000168436.76784.45

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  18 in total

1.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

2.  Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study.

Authors:  Jost Klawitter; Jelena Klawitter; Erich Kushner; Karen Jonscher; Jamie Bendrick-Peart; Dieter Leibfritz; Uwe Christians; Volker Schmitz
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

3.  Polylactide-cyclosporin A nanoparticles for targeted immunosuppression.

Authors:  Jamil Azzi; Li Tang; Robert Moore; Rong Tong; Najib El Haddad; Takurin Akiyoshi; Bechara Mfarrej; Sunmi Yang; Mollie Jurewicz; Takaharu Ichimura; Neal Lindeman; Jianjun Cheng; Reza Abdi
Journal:  FASEB J       Date:  2010-06-14       Impact factor: 5.191

4.  Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose.

Authors:  Jost Klawitter; Manuel Haschke; Christine Kahle; Colleen Dingmann; Jelena Klawitter; Dieter Leibfritz; Uwe Christians
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

5.  Clinical course of rhinosinusitis and efficacy of sinonasal evaluation in kidney transplant recipients: review of 1589 patients.

Authors:  Gwanghui Ryu; Min Young Seo; Kyung Eun Lee; Hyo Yeol Kim; Hun-Jong Dhong; Seung-Kyu Chung; Sang Duk Hong
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-20       Impact factor: 2.503

6.  Effects of cyclosporine, tacrolimus and rapamycin on renal calcium transport and vitamin D metabolism.

Authors:  Chien-Te Lee; Hwee-Yeong Ng; Yeong-Hau Lien; Li-Wen Lai; Mai-Szu Wu; Chung-Ren Lin; Hung-Chun Chen
Journal:  Am J Nephrol       Date:  2011-06-20       Impact factor: 3.754

7.  Impairment of long-term graft function after kidney transplantation by intraoperative vascular complications.

Authors:  Guido Fechner; Carolin von Pezold; Stefan Hauser; Thomas Gerhardt; Hans-Ulrich Klehr; Stefan C Müller
Journal:  Int Urol Nephrol       Date:  2008-05-06       Impact factor: 2.370

Review 8.  Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

Authors:  Dela Golshayan; Manuel Pascual
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506).

Authors:  Keiko Oh-i; Hiroshi Keino; Hiroshi Goto; Naoyuki Yamakawa; Masaru Takeuchi; Masahiko Usui; Takuya Iwasaki
Journal:  Br J Ophthalmol       Date:  2007-10-16       Impact factor: 4.638

Review 10.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.